Press release
Candidemia Market is Expected to Show a Healthy Growth Rate During the Study Period (2019-2032)| Key Companies- Pfizer, Cidera Therapeutics, and Others
Candidemia Market
Download Sample Report to know more @https://www.delveinsight.com/sample-request/candidemia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr
Candidemia Overview
Candidemia is a serious, life-threatening bloodstream infection and possibly the fourth most common all-type bloodstream infection seen in the intensive care unit setting. The incidence of Candida bloodstream infection is bimodal, with the elderly and very young having the highest risk of any population suffering from this disease.
Invasive fungal infections in critically ill patients are associated with considerable morbidity and mortality. Candida and Aspergillus species are the most frequent causes of healthcare-associated fungal infections in these patients. Although Candida infections are the most frequent fungal infections in ICU patients, invasive aspergillosis is associated with higher morbidity and mortality rates, even in the absence of traditional hematological risk factors. Occasionally, cryptococcosis, pneumocystosis, or zygomycosis may also be encountered in the ICU setting in patients with solid organ or hematopoietic stem cell transplantation, acquired immunodeficiency syndrome, cancer, or hematological malignancies.
Click here to learn more about the Candidemia Market Landscape @https://www.delveinsight.com/report-store/candidemia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr
Key Highlights from Candidemia Market Report
Key Pharmaceutical companies working in the Candidemia market include Pfizer, Cidara Therapeutics, Scynexis, and many others.
Key Therapies involved in the Candidemia market include APX001, CD101, SCY078, and many others.
Learn more about the treatment market for Candidemia @https://www.delveinsight.com/report-store/candidemia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr
The Report Covers the Candidemia Epidemiology Segmented by:
Candidemia Incident Cases
Candidemia Age-Specific Cases
Candidemia Gender-Specific Cases
Candidemia patients receiving the treatment
Candidemia Drug Profile and Companies Covered
Pfizer: APX001
Cidara Therapeutics: CD101
Scynexis: SCY078
And many others
Learn more about the Key Companies and Emerging Therapies in the Candidemia Market @ https://www.delveinsight.com/report-store/candidemia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr
Table of Contents
Key Insights
Candidemia Introduction
Executive Summary of Leber Hereditary Candidemia
Disease Background and Overview
Candidemia Epidemiology and patient population
Candidemia Emerging Therapies
Candidemia Market Outlook
Candidemia Market Access and Reimbursement of Therapies
Candidemia Market Drivers
Candidemia Market Barriers
Appendix
Candidemia Report Methodology
DelveInsight Capabilities
Disclaimer
Learn about the detailed offerings of the Candidemia Market Outlook report @ https://www.delveinsight.com/sample-request/candidemia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr
Related Reports
Candidemia Epidemiology Forecast
https://www.delveinsight.com/report-store/candidemia-epidemiology-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr
Candidemia Pipeline Forecast
https://www.delveinsight.com/report-store/candidemia-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr
Trending Reports By DelveInsight:
Functional Constipation Market
https://www.delveinsight.com/report-store/chronic-constipation-market
Lebers Hereditary Optic Neuropathy Lhon Market https://www.delveinsight.com/report-store/lebers-hereditary-optic-neuropathy-lhon-market
Gastric Neuroendocrine Tumors Market
https://www.delveinsight.com/report-store/gastric-neuroendocrine-tumors-market
Immune Thrombocytopenic Purpura Market
https://www.delveinsight.com/report-store/immune-thrombocytopenia-itp-market
Visceral Pain Associated With GI Disorders Market
https://www.delveinsight.com/report-store/visceral-pain-associated-with-gi-disorders-market
Bullous Pemphigoid Market
https://www.delveinsight.com/report-store/bullous-pemphigoid-market
Cyclin-dependent Kinase-like 5 Deficiency Disorder Market https://www.delveinsight.com/infographics/cyclin-dependent-kinase-like-5-cdkl5-deficiency-disorder-market
Myocarditis Market
https://www.delveinsight.com/report-store/myocarditis-market
Recurrent Blood Clots Market
https://www.delveinsight.com/report-store/recurrent-blood-clots-thrombophilia-market
Zollinger-ellison Syndrome Market
https://www.delveinsight.com/report-store/zollinger-ellison-syndrome-market
Age-related Hearing Loss Medical Device Market
https://www.delveinsight.com/blog/age-related-hearing-loss-device-market
Heart Sounds Sensors Market
https://www.delveinsight.com/report-store/heart-sounds-sensors-electronic-stethoscope-market
Hypoplastic Left Heart Syndrome Hlhs Market
https://www.delveinsight.com/report-store/hypoplastic-left-heart-syndrome-market
Infectious Arthritis/Septic Arthritis Market
https://www.delveinsight.com/report-store/infectious-arthritisseptic-arthritis-market
Plasmacytoma Market
https://www.delveinsight.com/report-store/plasmacytoma-market
Agoraphobia Market
https://www.delveinsight.com/report-store/agoraphobia-market
Clinically Isolated Syndrome CIS Market
https://www.delveinsight.com/report-store/clinically-isolated-syndrome-cis-market
Fucosidosis Market
https://www.delveinsight.com/report-store/fucosidosis-market
Major Depressive Disorder Market
https://www.delveinsight.com/report-store/major-depressive-disorder-market
Neuronal Ceroid-lipofuscinoses Market
https://www.delveinsight.com/report-store/neuronal-ceroid-lipofuscinoses-cln1-disease-market
Orthotic Devices Market
https://www.delveinsight.com/report-store/orthotic-devices-market
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.
DelveInsight Business Research LLP
Adya Kaul
info@delveinsight.com
https://www.delveinsight.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Candidemia Market is Expected to Show a Healthy Growth Rate During the Study Period (2019-2032)| Key Companies- Pfizer, Cidera Therapeutics, and Others here
News-ID: 3173719 • Views: …
More Releases from DelveInsight Business Research LLP
Epidermolysis Bullosa Pipeline Drugs 2025 Report: Uncovering Key Drug Developmen …
DelveInsight's "Epidermolysis Bullosa Pipeline Insight, 2025" report provides comprehensive insights about 20+ companies and 21+ pipeline drugs in Epidermolysis Bullosa pipeline landscape. It covers the Epidermolysis Bullosa pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Epidermolysis Bullosa pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Download our comprehensive report now to…
Cough in Idiopathic Pulmonary Fibrosis Pipeline 2025 Report: Detailed Overview o …
DelveInsight's "Cough in Idiopathic Pulmonary Fibrosis (IPF) Pipeline Insight, 2025" report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Cough in Idiopathic Pulmonary Fibrosis (IPF) pipeline landscape. It covers the Cough in Idiopathic Pulmonary Fibrosis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Cough in Idiopathic Pulmonary Fibrosis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It…
Vascular Dementia Pipeline Drugs Report 2025: Insightful Analysis of Upcoming Th …
DelveInsight's "Vascular Dementia Pipeline Insight, 2025," report provides comprehensive insights about 11+ companies and 11+ pipeline drugs in Vascular Dementia pipeline landscape. It covers the Vascular Dementia pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Vascular Dementia pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Download our comprehensive report now to…
RIPK1 Inhibitor Pipeline Insights Report 2025: Complete Analysis of Emerging The …
DelveInsight's, "RIPK1 inhibitor Pipeline Insight, 2025," report provides comprehensive insights about 10+ companies and 12+ pipeline drugs in RIPK1 inhibitor pipeline landscape. It covers the RIPK1 Inhibitor pipeline RIPK1 inhibitor drug profiles, including RIPK1 inhibitor clinical and nonclinical stage products. It also covers the RIPK1 inhibitor therapeutics assessment by product type, stage, RIPK1 inhibitor route of administration, and RIPK1 inhibitor molecule type. It further highlights the inactive pipeline products in…
More Releases for Candidemia
Candidemia Market Growth, Trends, Consumer Demand and Key Opportunities
Introduction
Candidemia, a bloodstream infection caused by Candida species, is one of the most severe forms of invasive candidiasis. It represents a major healthcare challenge worldwide, particularly in immunocompromised individuals, intensive care unit (ICU) patients, and those with central venous catheters. The infection is associated with high morbidity, mortality, and healthcare costs, making it a critical focus of antifungal research and hospital infection control programs.
The market is shaped by rising prevalence…
Candidemia Treatment Market 2034: Clinical Trials, Medication, Prevalence, Incid …
Candidemia companies working in the market are Basilea Pharmaceutica Ltd., Astellas Pharma Inc., Scynexis, Grupo Ferrer Internacional, S.A., Pacgen Life Science Corporation, NovaDigm Therapeutics, Inc., Cidara Therapeutics, Inc., Amplyx Pharmaceuticals Inc., Pfizer, and others.
(Albany, USA) DelveInsight's "Candidemia Market Insights, Epidemiology, and Market Forecast-2034" report delivers an in-depth understanding of Candidemia, historical and forecasted epidemiology as well as the Candidemia market trends in the United States, EU5 (Germany, Spain, Italy, France,…
Candidemia Market Size is Set for Rapid Growth as Innovative Treatments and Risi …
The Candidemia market size is expected to increase during the forecast period with the increasing prevalence, disease awareness, and promising emerging treatment options by leading companies such as Cidara Therapeutics, Mycovia Pharmaceuticals, Scynexis, GSK, Basilea Pharmaceutica, Pfizer, Astellas Pharma Inc, Gilead Sciences, Scynexis, Inc., Merck Sharp & Dohme LLC
[Nevada, United States] - DelveInsight's "Candidemia Market Insights, Epidemiology, and Market Forecast 2034." report offers a detailed examination of Candidemia, covering historical…
Candidemia Market Size Report 2032 | Market Drivers & Barriers, Clinical Trials …
(Albany, USA) DelveInsight's "Candidemia Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Candidemia, historical and forecasted epidemiology as well as the Candidemia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The Candidemia market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Candidemia market size from 2019 to…
Candidemia Market Forecast by 2032: Epidemiology Analysis, Emerging Therapies, R …
The Candidemia market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Candidemia pipeline products will significantly revolutionize the Candidemia market dynamics.
DelveInsight's "Candidemia Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Candidemia, historical and forecasted epidemiology as well as the Candidemia market trends in the United States, EU5 (Germany, Spain, Italy, France,…
Candidemia Market Report 2024-2034, Industry Size, Share, Trends and Future Grow …
Candidemia Market Size:
The candidemia market are expected to exhibit a CAGR of 3.16% during 2024-2034. The candidemia market report offers a comprehensive analysis of the market in the United States, EU5 (including Germany, Spain, Italy, France, and the United Kingdom), and Japan. It covers aspects such as treatment methods, drugs available in the market, drugs in development, the market share of various therapies, and the market's performance in the seven…
